Alnylam Pharmaceuticals Inc (ALNY)
257.91
-6.69
(-2.53%)
USD |
NASDAQ |
Nov 14, 16:00
256.21
-1.70
(-0.66%)
After-Hours: 20:00
Alnylam Pharmaceuticals Free Cash Flow (Quarterly): 39.52M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 39.52M |
| June 30, 2024 | 116.14M |
| March 31, 2024 | -94.49M |
| December 31, 2023 | -45.10M |
| September 30, 2023 | 342.32M |
| June 30, 2023 | -74.90M |
| March 31, 2023 | -180.37M |
| December 31, 2022 | -153.61M |
| September 30, 2022 | -131.79M |
| June 30, 2022 | -138.87M |
| March 31, 2022 | -189.05M |
| December 31, 2021 | -172.03M |
| September 30, 2021 | -160.10M |
| June 30, 2021 | -133.10M |
| March 31, 2021 | -252.84M |
| December 31, 2020 | -144.81M |
| September 30, 2020 | -122.74M |
| June 30, 2020 | -151.99M |
| March 31, 2020 | -265.78M |
| December 31, 2019 | -234.78M |
| September 30, 2019 | -218.69M |
| June 30, 2019 | 267.45M |
| March 31, 2019 | -232.56M |
| December 31, 2018 | -187.97M |
| September 30, 2018 | -199.22M |
| Date | Value |
|---|---|
| June 30, 2018 | -125.40M |
| March 31, 2018 | -176.92M |
| December 31, 2017 | -123.77M |
| September 30, 2017 | -124.04M |
| June 30, 2017 | -102.70M |
| March 31, 2017 | -136.48M |
| December 31, 2016 | -98.22M |
| September 30, 2016 | -95.83M |
| June 30, 2016 | -82.77M |
| March 31, 2016 | -95.44M |
| December 31, 2015 | -56.16M |
| September 30, 2015 | -60.84M |
| June 30, 2015 | -56.72M |
| March 31, 2015 | -28.36M |
| December 31, 2014 | -40.16M |
| September 30, 2014 | -43.90M |
| June 30, 2014 | -48.48M |
| March 31, 2014 | -42.06M |
| December 31, 2013 | -23.25M |
| September 30, 2013 | -22.66M |
| June 30, 2013 | -23.98M |
| March 31, 2013 | -2.77M |
| December 31, 2012 | -69.60M |
| September 30, 2012 | -0.517M |
| June 30, 2012 | -23.36M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-265.78M
Minimum
Mar 2020
342.32M
Maximum
Sep 2023
-107.42M
Average
-141.84M
Median
Free Cash Flow (Quarterly) Benchmarks
| Pfizer Inc | 6.063B |
| BridgeBio Pharma Inc | 72.26M |
| Biomarin Pharmaceutical Inc | 200.30M |
| Gilead Sciences Inc | 4.544B |
| Regeneron Pharmaceuticals Inc | 1.049B |